** Toothpaste maker Colgate-Palmolive CL.N forecast annual sales below Wall Street expectations after missing quarterly sales estimates on Friday, hurt by weak demand in North America and Latin America for its household products

** Median PT of 24 brokerages covering CL is $100 - LSEG data

RESILIENCE AMID MARKET UNCERTAINTY

** Morgan Stanley ("overweight", PT: $104) expects CL to maintain steady organic sales growth driven by strategic reinvestments, with a positive long-term outlook despite short-term challenges

** J.P. Morgan ("overweight", PT: $97) sees CL achieving moderate growth and improving profitability in 2025, despite facing challenges from currency fluctuations and tariffs

** Morningstar (fairvalue: $84) sees CL to keep investing heavily in R&D and marketing to strengthen its brand, while using strategic price hikes and new product innovations to counter currency impacts

** Stifel ("hold", PT: $93) is cautious about co's near-term performance due to slowing volume growth and market share concerns, despite some expected improvements in gross margin

** Stifel adds that they anticipate more modest gross margin expansion in 2025 compared to 2024, with increased but slowing ad spending

(Reporting by Rashika Singh in Bengaluru)

((rashika.singh@thomsonreuters.com))